EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis

Gairik Kundu, Rohit Shetty, Sharon D'Souza, Bhavya Gorimanipalli, Ameeta Koul, Swaminathan Sethu

Indian Journal of Ophthalmology · 2023

DOI: 10.4103/ijo.ijo_2909_22 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Gairik Kundu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Interleukin-10, Dry Eye Syndromes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to investigate the effects of maqui-berry extract (MBE) in improving signs and symptoms of dry eye disease (DED) along with ocular surface inflammation in patients with DED.

Methods

Twenty patients were randomly assigned to a MBE or a placebo group (PLC). DED parameters including Schirmer’s test 1 (ST1), tear film break-up time (TBUT), ocular surface disease index (OSDI), and corneal staining were assessed before treatment and 2 months post-treatment. Tear fluid samples before and after treatment from a subset of these patients were collected from the study subjects using sterile Schirmer’s strips, and the levels of interleukin (IL)-1β, IL-10, IL-6, IL-17A, tumor necrosis factor-α (TNFα), matrix metalloproteinase-9 (MMP9), soluble intercellular adhesion molecule-1 (sICAM1), and vascular endothelial growth factor-A (VEGF-A) were measured using a microfluidic cartridge-based multiplex ELISA.

Results

The MBE group demonstrated a significant ( p < 0.05) decrease in OSDI scores along with a significant increase in Schirmer’s test 1 compared to the PLC group. No significant change in TBUT and corneal staining was observed between the study groups. Levels of proinflammatory factors such as IL-1β, IL-6, IL-17A, TNFα, and MMP9 were observed to be significantly reduced, along with a significant increase in IL-10 levels following treatment in the MBE group compared with the PLC group.

Conclusion

Consumption of MBE resulted in the resolution of DED signs and symptoms, along with a reduction in ocular surface inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10Dry Eye SyndromesHumansInterleukin-17Matrix Metalloproteinase 9Vascular Endothelial Growth Factor ATumor Necrosis Factor-alphaFruitInterleukin-6TearsInflammation

Stichwörter der Autor:innen

CytokinesMaqui berrydelphinidindry eye diseaseinflammationtear fluid

Substanzen

Interleukin-10Interleukin-17Matrix Metalloproteinase 9Vascular Endothelial Growth Factor ATumor Necrosis Factor-alphaInterleukin-6

Autor:innen und Institutionen

  • Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India.
  • GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India.

Zitieren

APA

Kundu, G., Shetty, R., D'Souza, S., Gorimanipalli, B., Koul, A., & Sethu, S. (2023). Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2909_22

Vancouver

Kundu G, Shetty R, D'Souza S, Gorimanipalli B, Koul A, Sethu S. Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_2909_22

BibTeX
@article{Kundu2023,
  author = {Kundu, Gairik and Shetty, Rohit and D'Souza, Sharon and Gorimanipalli, Bhavya and Koul, Ameeta and Sethu, Swaminathan},
  title = {Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis},
  journal = {Indian Journal of Ophthalmology},
  year = {2023},
  doi = {10.4103/ijo.ijo_2909_22}
}
Kostenlos starten →